American International Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,942
| Closed | -$97.8K | – | 3119 |
|
|
2023
Q1 | $97.8K | Buy |
9,942
+198
| +2% | +$3.38K | ﹤0.01% | 2463 |
|
|
2022
Q4 | $182K | Sell |
9,744
-35
| -0.4% | -$793 | ﹤0.01% | 2176 |
|
|
2022
Q3 | $202K | Buy |
9,779
+1,206
| +14% | +$30.9K | ﹤0.01% | 2149 |
|
|
2022
Q2 | $178K | Buy |
8,573
+18
| +0.2% | +$507 | ﹤0.01% | 2269 |
|
|
2022
Q1 | $369K | Sell |
8,555
-602
| -7% | -$27.1K | ﹤0.01% | 1898 |
|
|
2021
Q4 | $548K | Sell |
9,157
-274
| -3% | -$22K | ﹤0.01% | 1752 |
|
|
2021
Q3 | $810K | Sell |
9,431
-224
| -2% | -$22.5K | ﹤0.01% | 1551 |
|
|
2021
Q2 | $1.07K | Buy |
9,655
+660
| +7% | +$63.4K | ﹤0.01% | 1476 |
|
|
2021
Q1 | $1K | Buy |
8,995
+1,314
| +17% | +$173K | ﹤0.01% | 1458 |
|
|
2020
Q4 | $816 | Sell |
7,681
-132
| -2% | -$17.6K | ﹤0.01% | 1505 |
|
|
2020
Q3 | $1.09M | Buy |
7,813
+481
| +7% | +$100K | 0.01% | 1205 |
|
|
2020
Q2 | $2.37M | Buy |
7,332
+2,651
| +57% | +$426K | 0.01% | 900 |
|
|
2020
Q1 | $418K | Sell |
4,681
-156
| -3% | -$9.62K | ﹤0.01% | 1513 |
|
|
2019
Q4 | $192K | Sell |
4,837
-41
| -0.8% | -$1.23K | ﹤0.01% | 2243 |
|
|
2019
Q3 | $120K | Buy |
4,878
+15
| +0.3% | +$456 | ﹤0.01% | 2494 |
|
|
2019
Q2 | $172K | Buy |
4,863
+244
| +5% | +$9.69K | ﹤0.01% | 2336 |
|
|
2019
Q1 | $207K | Buy |
4,619
+70
| +2% | +$3.53K | ﹤0.01% | 2191 |
|
|
2018
Q4 | $218K | Sell |
4,549
-35
| -0.8% | -$2.13K | ﹤0.01% | 2136 |
|
|
2018
Q3 | $306K | Buy |
4,584
+83
| +2% | +$4.62K | ﹤0.01% | 2159 |
|
|
2018
Q2 | $212K | Buy |
4,501
+162
| +4% | +$8.94K | ﹤0.01% | 2317 |
|
|
2018
Q1 | $245K | Sell |
4,339
-234
| -5% | -$12.7K | ﹤0.01% | 2156 |
|
|
2017
Q4 | $227K | Buy |
4,573
+76
| +2% | +$4.71K | ﹤0.01% | 2249 |
|
|
2017
Q3 | $342K | Buy |
4,497
+1,014
| +29% | +$75.5K | ﹤0.01% | 1981 |
|
|
2017
Q2 | $328K | Buy |
3,483
+78
| +2% | +$6.67K | ﹤0.01% | 1980 |
|
|
2017
Q1 | $270K | Buy |
3,405
+225
| +7% | +$17.9K | ﹤0.01% | 1981 |
|
|
2016
Q4 | $265K | Sell |
3,180
-8
| -0.3% | -$723 | ﹤0.01% | 2013 |
|
|
2016
Q3 | $357K | Buy |
3,188
+4
| +0.1% | +$442 | ﹤0.01% | 1810 |
|
|
2016
Q2 | $353K | Sell |
3,184
-488
| -13% | -$59.3K | ﹤0.01% | 1777 |
|
|
2016
Q1 | $384K | Sell |
3,672
-105
| -3% | -$8.11K | ﹤0.01% | 2208 |
|
|
2015
Q4 | $306K | Sell |
3,777
-1,277
| -25% | -$102K | ﹤0.01% | 2416 |
|
|
2015
Q3 | $351K | Buy |
5,054
+44
| +0.9% | +$3.83K | ﹤0.01% | 2325 |
|
|
2015
Q2 | $491K | Buy |
5,010
+698
| +16% | +$74.6K | ﹤0.01% | 2208 |
|
|
2015
Q1 | $422K | Sell |
4,312
-55
| -1% | -$5.33K | ﹤0.01% | 2301 |
|
|
2014
Q4 | $481K | Sell |
4,367
-271
| -6% | -$33.1K | ﹤0.01% | 2175 |
|
|
2014
Q3 | $548K | Buy |
4,638
+45
| +1% | +$5.61K | ﹤0.01% | 2056 |
|
|
2014
Q2 | $596K | Buy |
4,593
+2,737
| +147% | +$323K | ﹤0.01% | 2016 |
|
|
2014
Q1 | $297K | Sell |
1,856
-336
| -15% | -$48.2K | ﹤0.01% | 2495 |
|
|
2013
Q4 | $305K | Buy |
2,192
+1,775
| +426% | +$178K | ﹤0.01% | 2403 |
|
|
2013
Q3 | $41.4K | Buy |
+417
| New | +$35K | ﹤0.01% | 3815 |
|
Other funds holding INO
American International Group's INO Position: Q2 2023 in Review
American International Group sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 9,942 shares — an estimated $97.8K sold.
American International Group first reported a position in INO in Q3 2013 and held it in 39 quarters. The position peaked at $2.37M in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.
- American International Group reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- American International Group sold 9,942 Inovio Pharmaceuticals shares in Q2 2023, an estimated $97.8K.
- American International Group first reported a position in Inovio Pharmaceuticals in Q3 2013 and held it in 39 quarters.
- American International Group's Inovio Pharmaceuticals position peaked at $2.37M in Q2 2020.
- 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.
Based on American International Group's 13F filing for Q2 2023, filed 4 Aug 2023.